logo
The illusion of progress in US-China tariff talks — why the pause is not a reset

The illusion of progress in US-China tariff talks — why the pause is not a reset

Many Chinese workers may not realise the origin of their standard five-day, 40-hour work week.
Before 1995, workers in China only had one day off per week. Weekends, as they are understood today, simply didn't exist for the 1.2 billion Chinese population.
That changed when then-premier Li Peng issued a directive to align China's labour standards with international norms, facilitating its bid to join the World Trade Organization (WTO).
The policy shift marked a significant change in everyday life — an early and powerful example of how the Chinese government can reshape the rhythm of society overnight to serve strategic goals.
It symbolised Beijing's willingness to use its power to change the lifestyle of everyone in the country, as one of the outcomes of its 15-year negotiation with the United States.
The breakthrough of the working-hour system in China not just enhanced Beijing's will to open its door to the global market.
It was a symbol of adaptation — a gesture to a rules-based global economy.
But it also laid the foundations for today's differences with the US — tensions rooted in structural mismatches over trade, regulation and state power.
While the 90-day tariff truce between China and the US is seen as a relief and an optimistic message for the world, at the heart of the stand-off is a clash between fundamentally different systems.
The US increasingly views trade policy through a national security lens, aiming to reduce dependency on foreign supply chains, particularly those involving China.
Conversely, China remains committed to a model of state-led capitalism that prioritises global manufacturing dominance.
What's unfolding now is not a negotiation between equals, but a contest over who sets the rules — and whose system can withstand the pressure.
It's a clash of Xi Jinping's Chinese Dream and Donald Trump's America First.
Trade is no longer just about economics for the US — it has become a central part of its national security strategy.
The supply chain crisis during the COVID-19 pandemic exposed the fragility of relying on a single country — particularly China — for critical goods like pharmaceuticals and medical equipment.
In response, Washington has moved aggressively to "de-risk" and re-shore industries deemed strategic, including semiconductors, rare earths, and clean energy components.
The Biden administration's CHIPS and Science Act and Inflation Reduction Act are designed with this in mind: to reduce reliance on Chinese supply chains and invest in domestic capacity.
The logic is straightforward — if a geopolitical rival controls your access to essential goods, your security is compromised.
That logic now underpins bipartisan consensus in Washington. The Pentagon, the Commerce Department, and even Treasury are aligned in this approach.
Meanwhile, China continues to rely on the US to maintain its global trade dominance. The US remains one of China's largest export markets.
Access to the US not only brings revenue but also legitimises China's role in global commerce.
Since joining the WTO in 2001, China has used its manufacturing strength to climb the value chain, becoming the world's factory. But with that rise has come growing scrutiny.
At the core of the issue is how China uses its state apparatus to direct entire industries.
The Party can create a sector seemingly overnight — from solar panels to electric vehicles — through massive subsidies, cheap land, tax incentives, and government procurement.
The solar industry is one of the starkest examples.
In the early 2000s, Beijing picked it as a strategic priority. Within years, Chinese firms, backed by billions in subsidies, flooded the global market with low-cost panels, undercutting foreign competitors and forcing several Western manufacturers into bankruptcy.
The same playbook is now being applied to electric vehicles and battery technology.
But the Chinese system doesn't just build industries — it can also destroy them. Once state subsidies are withdrawn or redirected, whole sectors can collapse.
For domestic and international players alike, the uncertainty generated by this top-down industrial policy is a risk.
This dynamic — of building with the state and eroding competition through state support — has angered not only the US, but also the EU, Canada, and others.
The US has long accused China of failing to fulfil its WTO commitments.
These include promises to reduce subsidies, increase market access, and protect intellectual property.
However, over the years, Beijing has doubled down on support for state-owned and strategically chosen enterprises.
Despite entering the WTO as a developing country, China now dominates sectors it once pledged to liberalise.
In areas like digital trade and cloud services, the barriers to foreign firms remain high, while Chinese companies enjoy global access and home-market protection.
For Washington, this is no longer just about economics — it's about rules, reciprocity, and the contract of trust.
Trade deficits can be tolerated; systemic manipulation cannot.
That's why, even with a temporary tariff easing, the tone in Washington remains sceptical.
The current round of tariffs is broader than the last.
"Firstly, to prevent China from rerouting exports through third countries into the US.
"Secondly, this is no longer just economic competition — it's a mix of economic and national security concerns. Ultimately, it's about who controls the supply chains."
On the Chinese side, there is deep resistance to changing course.
Under Xi Jinping, the role of the Party in economic life has only strengthened.
Private firms are now expected to align with state goals. National champions like Huawei and BYD are not just businesses — they are arms of Beijing's broader global ambition.
The Belt and Road Initiative, too, is part of this strategy: to shape global economic flows in ways that favour Beijing's economic influence and geopolitical leadership.
So while China wants access to the US market to maintain growth, legitimacy, and influence, it's unwilling to concede control.
The ideological difference is stark.
In the West, competition is seen as a process governed by rules and independent oversight.
In China, the outcome — national strength — justifies the means.
"China should stop giving companies excessive subsidies. Its economic policy is not built on a fair system — but on doing whatever it takes to crush competitors.
"The US should focus on the fiscal deficit and public debt. Even after the 90-day truce ends, major structural issues will remain."
Even within the Asia-Pacific, this tension is playing out.
Countries like Japan, Indonesia and Malaysia, which once emulated aspects of China's state-driven model, are increasingly distancing themselves.
As their economies mature, they recognise the need to reduce market distortions and avoid over-reliance on a single dominant player.
This growing scepticism toward China's approach reflects a broader unease in the region.
In this context, the 90-day pause looks less like a breakthrough and more like a holding pattern.
It buys time — politically useful for both Trump and Xi, given the domestic pressures. But it postpones rather than resolves the conflict.
For Australia, this presents both risks and opportunities.
The trade relationship with China is strong, largely due to complementary rather than competitive industries.
But Canberra faces a strategic dilemma.
Economically, it can benefit from global supply chain shifts and Chinese demand.
Politically and militarily, it is tied closely to the US and must respond to the changing security environment.
Prime Minister Anthony Albanese will ultimately have to choose a side between national security and economic gains.
Australia stands to benefit economically from the rising geopolitical rivalry between China and the US.
"Compared with other countries, trade difficulties between China and Australia will be less."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Closing Bell: ASX ends flat, squeezed between resources and telecoms
Closing Bell: ASX ends flat, squeezed between resources and telecoms

News.com.au

time22 minutes ago

  • News.com.au

Closing Bell: ASX ends flat, squeezed between resources and telecoms

Resources stocks surge; materials sector up 3.02pc ASX 200 Banks fall, shedding 1.3% as finance loses 1.27pc Vietnam inks trade deal with US one week ahead of tariff-pause deadline ASX wobbles to the finish The ASX 200 was keeping us guessing right to the last minute there, briefly tipping into positive territory before ending trade at -0.02%. The ASX All Ords did end the day in the green, adding 0.06% on outsized gains from the materials sector (+3.02%). Resource stocks did the heavy lifting, supported by only energy (+0.82%) and healthcare (+0.60%). The ASX 200 Resources index climbed 2.82%, followed by smaller upticks in the Small Ords (+0.19%), All Tech (+0.19%) and All Ord Gold (+0.13%) indices. The ex-small cap movers were Pilbara Minerals (ASX:PLS) up 11%, Stanmore Resources (ASX:SMR) adding 10%, 29Metals (ASX:29M) up 8.9% and Whitehaven Coal (ASX:WHC), gaining 8.2%. Vietnam strikes trade deal with US As Trump's tariff deadline ticks closer, Vietnam has locked down a trade deal, shedding more than half of soon-to-be-imposed tariffs in the process. The US President took to Truth Social to announce the trade deal, calling it a 'Great Deal of Cooperation'. As part of the deal, tariffs on exports from Vietnam will be reduced to 20%, but goods that pass through the country in something called 'trans-shipping' will be slapped with a 40% import tax. In return, Hanoi has promised open trade with the US, charging no tariffs on US products. The details are once again elusive, but Vietnam has committed to "providing preferential market access for US goods, including large-engine cars," according to a government statement. The Trump Organization's plans to invest $1.5b in hotels, golf courses and luxury real estate alongside local partner Kinh Bac City Development has also been given the rubber stamp. One of the proposed developments is a Trump Tower in Ho Chi Minh City. The deal with Vietnam marks only the third to be publicly announced after the UK and China, leaving dozens of countries out in the cold as the July 9 tariff-pause deadline swiftly approaches. ASX SMALL CAP LEADERS Today's best performing small cap stocks: Security Name Last % Change Volume Market Cap SFM Santa Fe Minerals 0.14 352% 1639810 $2,257,382 AGY Argosy Minerals Ltd 0.034 79% 40878997 $27,662,498 OKJ Oakajee Corp Ltd 0.033 65% 547791 $1,828,921 REY REY Resources Ltd 0.015 50% 6666 $2,115,609 AXP AXP Energy Ltd 0.0015 50% 45000 $6,684,681 ICU Investor Centre Ltd 0.003 50% 171309 $609,023 PAB Patrys Limited 0.0015 50% 4369649 $2,365,810 IXR Ionic Rare Earths 0.018 38% 54768248 $68,476,535 NHE Nobleheliumlimited 0.035 35% 982639 $15,587,650 AMS Atomos 0.004 33% 1000000 $3,645,055 MRQ Mrg Metals Limited 0.004 33% 2668879 $8,179,556 PLG Pearlgullironlimited 0.008 33% 23200 $1,227,251 ALM Alma Metals Ltd 0.006 33% 4579516 $7,891,773 ICE Icetana Limited 0.07 30% 2037188 $28,718,599 WR1 Winsome Resources 0.165 29% 1937590 $31,096,415 G50 G50Corp Ltd 0.2 29% 419139 $24,892,637 AUG Augustus Minerals 0.027 29% 404104 $3,568,875 EQS Equitystorygroupltd 0.025 25% 175992 $3,336,408 1AD Adalta Limited 0.0025 25% 2979897 $2,142,633 AUK Aumake Limited 0.0025 25% 147767 $6,046,718 CUL Cullen Resources 0.005 25% 2837583 $2,773,607 FHS Freehill Mining Ltd. 0.005 25% 50000 $13,655,414 KPO Kalina Power Limited 0.005 25% 3581916 $11,731,983 MRD Mount Ridley Mines 0.0025 25% 4242 $1,556,978 THR Thor Energy PLC 0.01 25% 1103950 $5,686,319 Making news… Santa Fe Minerals (ASX:SFM) has laid claim to the Eburnea gold project, acquiring it from Turaco Gold (ASX:TCG) in return for 12 million shares, 4m performance rights and a potential 2.5% net smelter royalty. The company has also locked in commitments for a $1.2m share placement, offered at a 61% premium to its last closing price, to fund exploration at Eburnea. The project has produced broad gold hits of up to 26m at 4.82 g/t and a bonanza intersection of 3m at 35.79 g/t gold that SFM is keen to explore further. ASX SMALL CAP LAGGARDS Today's worst performing small cap stocks: Security Name Last % Change Volume Market Cap EEL Enrg Elements Ltd 0.001 -50% 85001 $6,507,557 BYH Bryah Resources Ltd 0.007 -42% 18326548 $10,439,442 CHRCA Charger Metals 0.01 -41% 5000 $726,049 VEN Vintage Energy 0.003 -40% 6621802 $10,434,568 CYQ Cycliq Group Ltd 0.002 -33% 175810 $1,381,550 CDE Codeifai Limited 0.056 -30% 29133426 $35,435,076 ADY Admiralty Resources. 0.005 -29% 100000 $18,406,356 CAV Carnavale Resources 0.003 -25% 6237500 $16,360,874 KLR Kaili Resources Ltd 0.006 -25% 14599 $1,179,203 SFG Seafarms Group Ltd 0.0015 -25% 83118 $9,673,198 MPP Metro Ltd 0.05 -24% 51732 $12,234,954 WWG Wisewaygroupltd 0.145 -22% 8140 $30,960,341 MSG Mcs Services Limited 0.004 -20% 1585283 $990,498 RLG Roolife Group Ltd 0.004 -20% 3461420 $7,963,906 LMS Litchfield Minerals 0.1 -17% 137626 $3,485,527 RCM Rapid Critical 0.0025 -17% 348017 $4,247,334 UBI Universal Biosensors 0.021 -16% 426388 $7,451,686 NOR Norwood Systems Ltd. 0.016 -16% 821111 $9,802,625 MDR Medadvisor Limited 0.064 -15% 3283092 $46,858,879 BLU Blue Energy Limited 0.006 -14% 835489 $12,956,815 MBK Metal Bank Ltd 0.012 -14% 372275 $6,964,426 REC Rechargemetals 0.013 -13% 664534 $3,854,850 RMI Resource Mining Corp 0.013 -13% 1144947 $11,016,800 OMG OMG Group Limited 0.007 -13% 94750 $5,826,359 TRI Trivarx Ltd 0.007 -13% 182013 $4,958,611 Making news… Bryah Resources (ASX:BYH) has purchased a 0.75% smelter royalty over two mining leases and four exploration licences that form part of the Bryah Basin manganese project. The royalty relates to manganese rights over the existing 3.066Mt at 20.2% manganese resource at Bryah Basin, purchased in return for 100 million BYH shares. IN CASE YOU MISSED IT StockTake: Trek Metals (ASX:TKM) has discovered a gold nugget field at its Turner prospect, part of the Christmas Creek project in WA. Break it Down: HyTerra (ASX:HYT) has discovered unexpectedly high levels of helium in a well the company is now converting for appraisal. Perth-based medtech Singular Health (ASX:SHG) has appointed radiologist Dr Alex Alonso as the approved US radiology expert under its binding enterprise agreement with Provider Network Solutions (PNS). Early drilling success at the TMT project has confirmed the potential of high-priority targets and reinforced confidence in Belararox's (ASX:BRX) exploration model. Golden Mile (ASX:G88) has intersected copper-lead in maiden drilling at the Pearl copper project. ClearVue Technologies' (ASX:CPV) solar glass is part of a new $20m RMIT-led project exploring how greenhouses could grow more food using less energy in a changing world. Sipa Resources (ASX:SRI) will shortly start drilling to infill and extend previously identified gold mineralisation at the Bimba and Sheoak prospects. Pure Hydrogen (ASX:PH2) has signed a distribution agreement with an Argentinian renewable energy company for its heavy-duty hydrogen fuel and battery electric vehicles. LAST ORDERS Theta Gold Mines (ASX:TGM) has completed a private $4m placement to Kong Ruihua Green Development Limited, an existing institutional investor and shareholder of TGM. Having made a decision to mine the TGME Gold Mine in South Africa, TGM is updating its feasibility study, targeting completion by Q3. The fresh capital will support the update, as well as early development works for the mine. TRADING HALTS Antipa Minerals (ASX:AZY) – cap raise BPM Minerals (ASX:BPM) – material tenement acquisition Chariot Corporation (ASX:CC9) – proposed acquisition Manuka Resources (ASX:MKR) – cap raise Unith (ASX:UNT) – cap raise At Stockhead, we tell it like it is. While Theta Gold Mines is a Stockhead advertiser, it did not sponsor this article.

Singular signs top US radiologist to pick up imaging rollout pace
Singular signs top US radiologist to pick up imaging rollout pace

West Australian

timean hour ago

  • West Australian

Singular signs top US radiologist to pick up imaging rollout pace

Western Australian medical technology innovator Singular Health Group has strengthened its push into the lucrative United States healthcare market with the appointment of a seasoned radiologist with more than two decades' experience as its US radiology advisor. In a move aimed squarely at cementing clinical credibility and accelerating commercialisation, Dr Alex Alonso will also set up Singular's flagship 3DICOM radiology platform at his own diagnostic centre, Life Radiology FL, in Doral, Florida. The appointment follows Singular's binding enterprise agreement with Provider Network Solutions (PNS), a leading US-based managed service organisation which manages more than 3.7 million patient plans across Florida, Texas and Puerto Rico. Chong described the appointment as a 'big win', noting his first-hand understanding of US imaging workflows and duplication challenges. Alonso said the technology could solve everyday challenges for radiologists and patients. 'I see a real pathway to nationwide rollout in the US as we move towards connected, patient-focused care, ' he said. Life Radiology will integrate 3DICOM features such as interoperability between digital patient filing systems, secure image sharing and patient access portals to streamline diagnostic workflows and reduce unnecessary repeat imaging, which remains a significant cost burden on the US healthcare system. Alonso's consulting fees will be settled through the issue of fully paid ordinary Singular shares worth US$27,000 at the end of his six-month engagement, directly aligning his interests with the company's shareholders. Today's appointment builds on a string of strategic milestones for Singular. Two weeks ago, the company inked a US$1.3 million (A$2 million) contract with PNS to roll out an initial 1000 3DICOM MD licences to doctors across Puerto Rico, Florida and Texas. The contract includes a US$500,000 commitment to develop AI imaging models and a centralised image repository, key steps towards the company's plan to address the endemic problem of duplicate imaging in the US. Industry studies estimate unnecessary imaging costs US healthcare up to US$30 billion annually. The scale of Singular's opportunity is underscored by independent research commissioned from Signify Research, estimating a total addressable market of US$19 billion annually for 3DICOM licences among 1.3 million US primary care doctors. To support its ambitious US rollout, Singular Health raised $8 million through a placement of 22.4 million shares at 35 cents each, completed just last week. The raise attracted strong institutional support and saw strategic backers, including PNS, reinforce their confidence in Singular's vision by participating in the placement. The fresh cash leaves the company fully funded for the planned national deployment of 3DICOM and further product development. Quarterly reports further reveal the company's solid operational and financial footing, with more than $5.3 million cash at bank as of the end of March. Recent achievements include the completion of the 3DICOM Gateway, a real-time browser-based tool enabling seamless sharing and access to imaging records, and the appointment of Australian radiologist Dr Ronny Low as technical advisor for the US pilot. Looking ahead, Singular Health is preparing for its first large-scale national rollout across PNS's partner networks, supported by its strategic joint venture between PNS and the Healthcare Outcomes Performance Company (HOPCo), a group operating across more than 30 US states. Singular Health's 3DICOM software, which has US Food and Drug Administration registration for diagnostic use in the US, enables advanced 3D visualisation of medical images, empowering practitioners and patients with clearer insights into imaging data. The company's broader suite of technologies, including its volumetric rendering platform and medical file transfer protocol, aims to eliminate medical imaging silos and reduce costs, patient discomfort and delays in care. As Singular Health sets its sights firmly on transforming the US medical imaging landscape, today's appointment of Alonso represents a clinical endorsement and a significant leap forward in its mission to make healthcare imaging smarter, faster and more accessible across America. Is your ASX-listed company doing something interesting? Contact:

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store